Northern Trust’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.1K | Sell |
|
|||||
|
2025
Q1 | $37.9K | Hold |
|
|||||
|
2024
Q4 | $80.3K | Sell |
|
|||||
|
2024
Q3 | $70.1K | Sell |
|
|||||
|
2024
Q2 | $74.2K | Buy |
|
|||||
|
2024
Q1 | $113K | Hold |
|
|||||
|
2023
Q4 | $86.1K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $13.4K | Hold |
|
|||||
|
2022
Q3 | $20K | Hold |
|
|||||
|
2022
Q2 | $35K | Hold |
|
|||||
|
2022
Q1 | $58K | Hold |
|
|||||
|
2021
Q4 | $91K | Sell |
|
|||||
|
2021
Q3 | $213K | Buy |
|
|||||
|
2021
Q2 | $346K | Sell |
|
|||||
|
2021
Q1 | $2.69M | Buy |
|
|||||
|
2020
Q4 | $2.44M | Sell |
|
|||||
|
2020
Q3 | $2.61M | Buy |
|
|||||
|
2020
Q2 | $2.25M | Buy |
|
|||||
|
2020
Q1 | $1.23M | Buy |
|
|||||
|
2019
Q4 | $699K | Sell |
|
|||||
|
2019
Q3 | $710K | Buy |
|
|||||
|
2019
Q2 | $648K | Buy |
|
|||||
|
2019
Q1 | $785K | Buy |
|
|||||
|
2018
Q4 | $406K | Sell |
|
|||||
|
2018
Q3 | $970K | Buy |
|
|||||
|
2018
Q2 | $548K | Sell |
|
|||||
|
2018
Q1 | $2.58M | Buy |
|